Sonali Thosani

965 total citations
23 papers, 582 citations indexed

About

Sonali Thosani is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Sonali Thosani has authored 23 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Surgery. Recurrent topics in Sonali Thosani's work include Cancer Immunotherapy and Biomarkers (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Sonali Thosani is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Metabolism, Diabetes, and Cancer (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Sonali Thosani collaborates with scholars based in United States, Colombia and Spain. Sonali Thosani's co-authors include Mimi I. Hu, Nirav Thosani, Victor Lavis, Camilo Jiménez, Sushovan Guha, Steven G. Waguespack, Naifa L. Busaidy, Manoop S. Bhutani, Wei Qiao and Jason B. Fleming and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Clinical Endocrinology & Metabolism and Diabetes.

In The Last Decade

Sonali Thosani

19 papers receiving 571 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sonali Thosani United States	10	326	251	179	162	113	23	582
Masatoshi Iihara Japan	16	228 0.7×	250 1.0×	209 1.2×	166 1.0×	63 0.6×	30	592
Roxanne Merkel United States	12	217 0.7×	100 0.4×	119 0.7×	173 1.1×	47 0.4×	16	459
J F Henry France	18	161 0.5×	481 1.9×	550 3.1×	216 1.3×	43 0.4×	32	855
Rose Chami Canada	13	117 0.4×	240 1.0×	111 0.6×	123 0.8×	33 0.3×	42	526
Sheila Lindsay United States	12	189 0.6×	117 0.5×	296 1.7×	136 0.8×	53 0.5×	19	569
Nikos Courcoutsakis Greece	12	130 0.4×	211 0.8×	86 0.5×	96 0.6×	16 0.1×	26	527
J A Norton United States	13	483 1.5×	351 1.4×	150 0.8×	486 3.0×	60 0.5×	16	940
R. Pellerito Italy	13	94 0.3×	173 0.7×	184 1.0×	88 0.5×	23 0.2×	31	556
Andreas Muth Sweden	17	89 0.3×	604 2.4×	525 2.9×	69 0.4×	311 2.8×	48	857
M Arganini Italy	12	171 0.5×	300 1.2×	437 2.4×	99 0.6×	34 0.3×	28	650

Countries citing papers authored by Sonali Thosani

Since Specialization

Citations

This map shows the geographic impact of Sonali Thosani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sonali Thosani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sonali Thosani more than expected).

Fields of papers citing papers by Sonali Thosani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sonali Thosani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sonali Thosani. The network helps show where Sonali Thosani may publish in the future.

Co-authorship network of co-authors of Sonali Thosani

This figure shows the co-authorship network connecting the top 25 collaborators of Sonali Thosani. A scholar is included among the top collaborators of Sonali Thosani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sonali Thosani. Sonali Thosani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lavis, Victor, et al.. (2025). Etiologies and Outcomes of Diabetic Ketoacidosis in Cancer Patients: A Retrospective Analysis. Cancers. 17(17). 2728–2728.

Kotwal, Anupam, et al.. (2024). Endocrinopathies Associated With Immune Checkpoint Inhibitor Use. Endocrine Practice. 30(6). 584–591. 5 indexed citations

Taylor, Jolyn, Bryan Fellman, Katherine Cain, et al.. (2024). Glycemic control to improve post-operative outcomes in patients with type 2 diabetes mellitus: Results of the SUGAR (Surgical Universal euGlycemic Attainment during Recovery) initiative. International Journal of Gynecological Cancer. 35(1). 100003–100003.

Taylor, Jolyn, Bryan Fellman, Sally Raty, et al.. (2024). Detection and Management of Perioperative Hyperglycemia at a Tertiary Cancer Center. Annals of Surgical Oncology. 31(5). 3017–3023. 1 indexed citations

Thosani, Sonali, et al.. (2024). #1698936 Hyperglycemia in a Novel CDK2 and CDK9 inhibitor-Fadraciclib. Endocrine Practice. 30(5). S32–S32.

Thosani, Sonali & Arlene O. Siefker‐Radtke. (2023). Abstract #1407620: Enfortumab Vedotin Associated Refractory Diabetic Ketoacidosis, Rash and Altered Mental Status. Endocrine Practice. 29(5). S23–S23. 3 indexed citations

Lavis, Victor, et al.. (2021). Diabetic Ketoacidosis With Alpelisib. Journal of the Endocrine Society. 5(Supplement_1). A376–A377. 5 indexed citations

Iyer, Priyanka, et al.. (2021). Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center. Journal of the Endocrine Society. 5(Supplement_1). A415–A416. 1 indexed citations

Turin, Christie G., et al.. (2020). A Case of Acquired Generalized Lipodystrophy Associated with Pembrolizumab in a Patient with Metastatic Malignant Melanoma. AACE Clinical Case Reports. 6(1). e40–e45. 20 indexed citations

10.

Iyer, Priyanka, Maria E. Cabanillas, Steven G. Waguespack, et al.. (2018). Immune-Related Thyroiditis with Immune Checkpoint Inhibitors. Thyroid. 28(10). 1243–1251. 154 indexed citations

11.

Iyer, Priyanka & Sonali Thosani. (2018). Euglycemic DKA as an Initial Presentation of Immunotherapy-Induced Insulin-Dependent Diabetes. Diabetes. 67(Supplement_1).

12.

Tatsui, Claudio E., et al.. (2017). Treatment for Malignant Pheochromocytomas and Paragangliomas: 5 Years of Progress. Current Oncology Reports. 19(12). 83–83. 49 indexed citations

13.

Thosani, Sonali, et al.. (2016). Co-Managing Patients with Type 1 Diabetes and Cancer. Current Diabetes Reports. 16(8). 73–73. 1 indexed citations

14.

Thosani, Sonali & Mimi I. Hu. (2015). Denosumab: A New Agent in the Management of Hypercalcemia of Malignancy. Future Oncology. 11(21). 2865–2871. 30 indexed citations

15.

Thosani, Sonali, et al.. (2014). Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy. Diabetes Technology & Therapeutics. 16(12). 874–879. 23 indexed citations

16.

Thosani, Sonali, Montserrat Ayala‐Ramirez, Lynn Palmer, et al.. (2013). The Characterization of Pheochromocytoma and Its Impact on Overall Survival in Multiple Endocrine Neoplasia Type 2. The Journal of Clinical Endocrinology & Metabolism. 98(11). E1813–E1819. 68 indexed citations

17.

Thosani, Nirav, Sonali Thosani, Sheetanshu Kumar, et al.. (2012). Reduced Risk of Colorectal Cancer With Use of Oral Bisphosphonates: A Systematic Review and Meta-Analysis. Journal of Clinical Oncology. 31(5). 623–630. 39 indexed citations

18.

Yeung, Sai‐Ching J., Mouhammed Amir Habra, & Sonali Thosani. (2011). Lung cancer-induced paraneoplastic syndromes. Current Opinion in Pulmonary Medicine. 17(4). 260–268. 19 indexed citations

19.

Thosani, Sonali & Camilo Jiménez. (2011). Opioid-induced biochemical alterations of the neuroendocrine axis. Expert Review of Endocrinology & Metabolism. 6(5). 705–713. 4 indexed citations

20.

Thosani, Nirav, Sonali Thosani, Wei Qiao, et al.. (2010). Role of EUS-FNA-Based Cytology in the Diagnosis of Mucinous Pancreatic Cystic Lesions: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences. 55(10). 2756–2766. 107 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact